Latest News
Michelson Medical Research Foundation: 2024 February Newsletter
Dr. Gary K. Michelson and California Governor Gavin Newsom, pictured with State Senator Ben Allen and Michelson Philanthropies Co-chair Alya Michelson, announce the establishment of the revolutionary new California Institute for Immunology and Immunotherapy (CIII).
Nominations Open for the 2024 Victor Cohn Prize in Medical Science Reporting
Underwritten by Michelson Philanthropies, the $5,000 prize honors a writer for a body of work which, for reasons of accuracy, enterprise, insight, and narrative power, has made a profound contribution to public understanding of critical advances in medical science and their impact on human health.
Governor Newsom Unveils California Institute for Immunology & Immunotherapy: A Revolutionary Leap in Science and Medicine
The Institute will unite California's medical research assets to foster inter-institutional dream teams, promote health, and cultivate a thriving biotech ecosystem.
T Cell Research Breakthrough by Michelson Prize Recipient Dr. Mamedov Published in Nature
Mamedov and the team used CRISPR technology—a Nobel Prize winning gene-editing tool—to disrupt thousands of genes in lymphoma cells.
How Unique Immune Cells Can Recognize and Destroy Tumors
San Francisco— Gamma delta T cells, a special type of cell in the immune system, are incredibly effective at recognizing and killing cancer cells. Cancer patients with higher levels of these T cells in their tumors tend to fare better than those with lower levels.
Maryn McKenna's Award-Winning Reporting on Infectious Diseases and Global Health
McKenna is being honored for her reporting and writing on infectious diseases and global health and was selected from an extraordinarily competitive field of nominees.
Maryn McKenna Awarded 2023 Victor Cohn Prize
Los Angeles— Maryn McKenna (@marynmck), senior writer at WIRED and a widely published journalist and author specializing in public health, global health, and food policy, has been selected to receive the 2023 Victor Cohn Prize for Excellence in Medical Science Reporting.
Michelson Philanthropies & Science Prize: Breakthrough Discoveries in Human Immunology Keystone ePanel
This ePanel event will honor the exceptional achievements of the 2023 awardees of the Michelson Philanthropies & Science Prize for Immunology.
Roser Vento-Tormo’s Michelson Prize Finalist Research: Decoding the Human Immune System
To conduct their research, Vento-Tormo and her lab use genomics and imaging tools to construct physiological environments that mimic organs such as the placenta or the testis.
Michelson Prize Finalist Dr. Joshua Tan’s Research Explores the Power of Monoclonal Antibodies to Treat Diseases
Dr. Joshua Tan, a finalist for the 2023 Michelson Philanthropies & Science Prize for Immunology, is working towards identifying powerful monoclonal antibodies to combat diseases like COVID-19.
Breaking New Ground: Dr. Aleksandar Obradovic's Research on Precision Immunotherapy Wins 2023 Michelson Prize
Dr. Obradovic, associate research scientist in the Department of Systems Biology at Columbia University Irving Medical Center, was awarded the 2023 Michelson Philanthropies & Science Prize for Immunology grand prize in recognition of his essay: “Precision Immunotherapy – A Mechanistic Approach to Overcoming Treatment Resistance.”
Breakthrough Discoveries in Human Immunology – Michelson Philanthropies and Science/AAAS Award Transformative Research
Michelson Philanthropies and AAAS/Science announce the recipients of the 2023 Michelson Philanthropies & Science Prize for Immunology.
Pioneering a New Era of Intranasal Vaccinations: Dr. Brittany Hartwell’s Research is Recognized with 2022 Michelson Prize
Engineered to bypass mucosal barriers and improve mucosal uptake, Dr. Brittany Hartwell's intranasal vaccine promises stronger immune responses and immunity.
Oxford Researcher Romain Guyon Receives Michelson Prize for Work on Single-dose Rabies Vaccine
Romain Guyon, a Ph.D. student at the University of Oxford, is currently researching a single-dose vaccination against a disease that is widely-known, but mistakenly perceived as having little impact on human health
USC Michelson Center: Celebrating 5 Years of Interdisciplinary Innovation
Drawn from across a broad spectrum of research fields, ranging from computational sciences and applied mathematics to nanoengineering, biology, and medicine, Michelson Faculty, along with hundreds of postdocs, students, and research administrative staff, represent the human capital supporting the convergence of research at USC.
Artificial Intelligence Meets Immunology: Dr. Noam Auslander, 2022 Michelson Prize Recipient, Brings a New Approach to Cancer Diagnosis and Treatment
Dr. Noam Auslander’s work in artificial intelligence and immunology was born out of indecision. “I double majored in computer science and biology because I liked both and could not decide.”
Unlocking the Secrets of Immunity: Meet Dr. Jenna Guthmiller, 2022 Michelson Prize Recipient and Influenza Vaccine Innovator
Jenna Guthmiller first learned about immunology growing up on her family’s dairy farm, where her parents showed her the importance of vaccines to an animal’s health. “The idea that a dead or weakened version of a pathogen could provide protection against something that would otherwise make the animals sick was fascinating to me,” says Guthmiller.
Michelson Prizes - Next Generation Grants: Advancing Immunology and Vaccine Innovation
This program features the recipients of the Michelson Prizes: Next Generation Grants, an international prize that supports early-career researchers who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research.
The Next Generation of Global Health Innovators: Michelson Prize Winners Announced
The Michelson Medical Research Foundation and the Human Immunome Project award Dr. Noam Auslander, Dr. Jenna Guthmiller, Mr. Romain Guyon, and Dr. Brittany Hartwell with the Michelson Prizes: Next Generation Grants.
Philanthropy’s Role in Advancing mRNA Technology
Maintaining mRNA’s momentum will require continued investment, effective collaboration, and philanthropic contributions, Dr. Thomas Conlon of Michelson Philanthropies said on a panel at the Milken Institute’s Future of Health Summit.
